Achieve Equine to Attend BEVA

Achieve Equine, LLC is pleased to announce its upcoming attendance at the British Equine Veterinary Association 2022 Congress September 7-10 at the ACC in Liverpool, UK. Jim Chiapetta, DMV, JD, and Hanna Hartman, Director of Operations, will be at stand F03 to educate Congress attendees about the use and benefits of FLAIRÒ Equine Nasal Strips for the equine athlete. It will be an exciting opportunity to share information and interact with leading practitioners and world-renowned specialists. With over 100 exhibitors, Achieve Equine will be in good company to catch up with leading organizations as equine vets from across the globe gather to discover and learn. BEVA has a full scientific program and, with an emphasis on education, Achieve Equine is pleased to attend to share the clinical research done on FLAIR Strips and their benefits for equine respiratory health.

 About Achieve Equine, LLC: Achieve Equine is a worldwide distributor of innovative, evidence-based products. We partner with carefully selected equine brands to deliver safe, functional and validated technologies that improve the health and safety of horse and rider. Achieve Equine is the maker of FLAIR® Equine Nasal Strips and the exclusive North American distributor of VIP Equestrian™ Half Pads and Iconic Equestrian™ Saddle Pads. For more information, please visit

About FLAIR Equine Nasal Strips: Developed by veterinarians, FLAIR Strips are drug-free, self-adhesive nasal strips that support horses’ nasal passages and promote optimum respiratory health of equine athletes at every level of competition. Eight clinical studies have been conducted on FLAIR Strips at leading equine research centers. The Strips are clinically proven to make breathing easier, reduce fatigue, conserve energy, quicken recovery, and reduce lung bleeding. Visit to learn more and shop today.

Contact: Hanna Hartman

Images available upon request.

AHP has not verified the factual statements in any message and AHP assumes no responsibility for the contents of, or any damage resulting from, any communication in the Newsgroup. Publication in the Newsgroup is not an endorsement by the organization of any product, person, or policy.